Acorda Therapeutics reported $-16703000 in Operating Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -113.02M 68.36M
Acorda Therapeutics ACOR:US $ -16.7M 5.14M
Agios Pharmaceuticals AGIO:US $ -98.44M 3.74M
ALKERMES ALKS:US -26585000 28.97M
Amgen AMGN:US $ 2500M 196M
Anika Therapeutics ANIK:US $ -3.55M 5.57M
Aptinyx Inc APTX:US $ -19379000 207K
Arrowhead Research ARWR:US $ 41.55M 104.87M
Biogen BIIB:US $ 610.7M 23.6M
Biomarin Pharmaceutical BMRN:US $ 137.33M 203.21M
Cara Therapeutics CARA:US $ -27911000 5.61M
Clovis Oncology CLVS:US $ -50.36M 4.68M
Cytokinetics CYTK:US $ -80.55M 58.85M
Enanta Pharmaceuticals ENTA:US $ -33.85M 3.44M
Gilead Sciences GILD:US $ 197M 743M
GlaxoSmithKline GSK:LN 2.8B 1.91B
Halozyme Therapeutics HALO:US $ 75.67M 19.14M
Heron Therapeutics HRTX:US $ -62.92M 9.39M
Insmed INSM:US $ -89833000 9.24M
Ligand Pharmaceuticals LGND:US $ -7.81M 20.54M
Mannkind MNKD:US $ -21.26M 2.71M
Merck MRK:GR € 1173M 134M
Moderna Inc MRNA:US 4.23B 1.18B
Neurocrine Biosciences NBIX:US $ 3.1M 39.4M
Novartis NOVN:VX 2.85B 290M
Pfizer PFE:US $ 9873M 5297M
Teva Pharmaceutical TEVA:IT -713000000 791M
Ultragenyx Pharmaceutical RARE:US $ -136.63M 34.07M
Vertex Pharmaceuticals VRTX:US $ 1040.9M 163.18M